- ￥11800
- 爱必信(Absin)
- 中国
- abs6105221
- 2025年07月15日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存：
99
- 供应商：
爱必信（上海）生物科技有限公司
- 规格：
1kit
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Gene Therapy for Hypertension: Antisense Inhibition of the Renin-Angiotensin System
to be overactive in hypertension and that are proven targets of current drug treatments. These include β1-receptors, angiotensin-converting enzyme (ACE), and angiotensin type 1 receptors (AT1R). Antisense oligonucleotides are short (12-20 bases), single strands
us to change genomic sequences at will to control the fundamental geneticinformation within a cell. It has been implemented in creatingmodel cell lines or organisms for the study of gene functions orgenetics of human diseases, and in gene therapy
Genetic Manipulation of the Renin-Angiotensin System Using Cre-loxP-Recombinase
of weaning. This is observed in angiotensinogen (Agt-/-), angiotensin-converting enzyme (ACE-/-), and combined angiotensin receptor subtype 1A and 1B (At1a-/-, At1b-/-) deficient “knockout” mice (1 –5 ). Mice deficient in At1a, but wild type at the At1
技术资料暂无技术资料 索取技术资料
